Authid Inc. (Ipsidy Inc.) 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Ipsidy Inc. (referred to as Authid Inc. in metadata) on August 15, 2018. The filing discloses a material definitive agreement and unregistered sales of equity securities involving a private placement of common stock to accredited investors.
Key Financial Metrics
The filing details a capital raise rather than operational financial performance. Key transaction metrics include:
- Total Capital Raised: Approximately $9.6 million.
- Shares Issued: 64,071,998 shares of common stock.
- Implied Price per Share: Approximately $0.15 (derived from aggregate price and share count).
- Transaction Fees: Approximately $630,000 cash fee paid to Network 1 Financial Securities, Inc.
- Warrant Issuance: Warrants issued to the underwriter to acquire approximately 2,471,000 shares at an exercise price of $0.165, exercisable for five years.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions as this is a transactional report, not a periodic financial statement.
Material Changes
The primary material change is the increase in outstanding common stock by 64,071,998 shares and the corresponding increase in cash assets from the $9.6 million offering. The company also incurred a liability or expense related to the $630,000 underwriting fee and the issuance of warrants.
Outlook, Risks, and Contingencies
The securities were sold pursuant to exemptions under Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D. No advertising or general solicitation was employed. The shares issued are restricted in transfer in accordance with the Securities Act. The filing notes that the summary is qualified by reference to the full text of the Subscription Agreements attached as exhibits.
Investor Verification Checklist
- Verify the exact number of shares outstanding post-transaction to assess dilution impact.
- Review the full text of the Subscription Agreement (Exhibit 4.1) for specific terms, covenants, or redemption rights.
- Confirm the use of proceeds for the $9.6 million raised, as this is not explicitly detailed in the summary text.
- Assess the impact of the warrant issuance (2,471,000 shares at $0.165) on future potential dilution.